Infections: News and Research on Tuberculosis, Multidrug-Resistant

MeSH tree: C01.150.252.410.040.552.846.775

J&J loses key tuberculosis drug patent in India

India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.

Shorter treatment effective for drug-resistant tuberculosis

Two treatment regimens for multidrug-resistant tuberculosis (TB), containing the first new drug to have been discovered for the disease in 40 years, are more effective than a previously recommended treatment, according to ...

page 5 from 5